Adverum Biotechnologies Other Long Term Liabilities (Quarterly) Analysis

Adverum Biotechnologies, Inc. (ADVM)

4.36 0.00 (0.00%) USD | NASDAQ | Jan 12, 16:00

View Other Long Term Liabilities (Quarterly) for ADVM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Pfizer Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade
Quantum-Si, Inc.	Upgrade
X4 Pharmaceuticals, Inc.	Upgrade